NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Oracle Borrows Billions for AI Cloud Expansion

Oracle is raising $15 billion through bonds to fund massive cloud infrastructure deals with companies like OpenAI and Meta, boosting its AI capabilities despite rising costs.

Oracle Borrows Billions for AI Cloud Expansion
“Oracle Logo on Setagaya Business Square Tower in Yoga” by ykanazawa1999, CC BY-NC-SA 2.0
Already have an account? Sign in.
Featured/ 09/24/2025 · 10:02 AM
ORCL
/ Don't stop with just one post.

Related↓

AI Data Center
Featured/ 10/16/2025 · 2:50 PM

Oracle Shares Surge After Revealing Strong AI Infrastructure Profit Margins

Oracle shares spike 4% after revealing 30-40% margins on AI infrastructure deals with OpenAI, Meta, and xAI. Company expects cloud revenue to hit $166B by 2030.

/ Subscriber only
Astera Labs
10/15/2025 · 6:02 AM

Astera Labs Joins Arm Total Design to Accelerate Custom AI Chip Development

Astera Labs partners with Arm Total Design to deliver chiplet connectivity for AI infrastructure using PCIe, CXL, and UALink amid recent stock volatility.

/ Subscriber only
Bloom Energy solid oxide fuel cells
Featured/ 10/13/2025 · 8:15 AM

Brookfield Invests Up to $5 Billion to Deploy Bloom Energy's Advanced Fuel Cells for AI Infrastructure

Bloom Energy and Brookfield announce groundbreaking $5 billion partnership to build next-generation AI factories with advanced fuel cell technology, addressing massive power demands.

/ Subscriber only
/ Read more

Feed↓

Hologic logo
10/18/2025 · 3:56 AM

Blackstone and TPG Eye $17 Billion Hologic Acquisition

Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.

Clear Channel Outdoor logo
10/17/2025 · 3:51 PM

Abu Dhabi's Mubadala Eyes Clear Channel Billboard Business

Mubadala Capital explores acquisition of Clear Channel Outdoor Holdings as outdoor advertising deals heat up globally. Stock jumps 19% on takeover speculation.

/ Subscriber only
Roche logo
10/17/2025 · 2:37 PM

Viridian Therapeutics Gets Double Buy Rating After Roche's Weak TED Results

Jefferies and Wedbush maintain Buy ratings on Viridian Therapeutics as Roche's thyroid eye disease drug shows weaker results than Viridian's veligrotug therapy.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe